Abbott (NYSE:ABT) announced today that the FDA has approved its low-dose, recharge-free spinal cord stimulation system with up to 10-year battery life for people in chronic pain. The Proclaim XR neurostimulation system couples low-energy therapy with a low-dosing protocol to provide pain relief and preserve its battery. Abbott said its BurstDR stimulation waveform was designed to […]
ElectroCore plunges after FDA asks for more GammaCore data
ElectroCore (NSDQ:ECOR) shares plunged today after the company said the FDA asked for more data on a bid for an expanded indication for its GammaCore device. Basking Ridge, N.J.-based ElectroCore asked for an expanded 510(k) indication covering prevention of migraine with ElectroCore, a non-invasive vagus nerve stimulator. Today the company said the federal safety watchdog asked […]
Stimwave appeals injunction in Nevro patent war
Stimwave yesterday appealed a preliminary injunction barring it from using higher-frequency neurostim to treat chronic pain in a patent spat with rival Nevro (NYSE:NVRO). Redwood City, Calif.-based Nevro brought the suit in February, alleging that Stimwave infringed on patents related to Nevro’s Senza system and HF10 therapy. The lawsuit, filed in the U.S. District Court for Delaware, […]
MedTech Innovator announces five finalists in competition
MedTech Innovator last week announced the five finalists for its $500,000 competition. The organization will award more than $500,000 in prizes to the finalists with first place taking $350,000 and the four remaining finalists taking $25,000. Five finalists will have seven minutes to pitch their technologies to a panel of four judges. The audience will […]
Former NFL player may pursue pain pump lawsuit against Stryker, I-Flow
A former NFL player may proceed with a federal lawsuit against Stryker (NYSE:SYK) and I-Flow over a pain pump that the player claims destroyed the cartilage in his shoulder. U.S. District Court Judge Gloria Navarro ruled last week that former New England Patriots linebacker Ryan Claridge could add specifics to his claim that Stryker and […]
Flowonix warns on software anomaly with Prometra pump
Flowonix earlier this month warned about a software anomaly with its Prometra infusion pump that could unexpectedly shut down the device. The Budd Lake, N.J.-based company won FDA approval in February for updated software included in the Prometra system, which is indicated for intrathecal infusion of drug therapy, including infumorph, saline and baclofen. Flowonix warned […]
Nevro beats the Street with Q2 results
Shares in Nevro (NYSE:NVRO) rose this week after the medical device maker topped expectations on Wall Street with its second-quarter financial results. The Redwood City, Calif.-based company posted a net loss of -$28 million on sales of $93.6 million for the three months ended June 30. Compared with the same period last year, Nevro’s revenue fell […]
Ocular Therapeutix’s ophthalmic device gains Medicare coverage early
Ocular Therapeutix (NSDQ:OCUL) said today that the Centers for Medicare and Medicaid Services has assigned a specific and permanent reimbursement J-code for its Dextenza ophthalmic insert, which is approved for the treatment of ocular inflammation and pain following ophthalmic surgery. The code assigned to Dextenza through the Healthcare Common Procedure Coding System will become effective on […]
5 Wearable Technologies Conference exhibitors you should know
The 34th edition of the Wearable Technologies Conferenceseries is taking place today and tomorrow in San Francisco. Co-located with Semicon West, the Wearable Technologies Conference offers a number of panels to discuss wearables in healthcare and IoT, as well as conference exhibitors and networking opportunities. Here are five companies touting their latest wearable technologies at this […]
Boston Scientific gets in on $75m round for Saluda Medical
A day after taking out a loan from Medtronic (NYSE:MDT), Saluda Medical brought in $75 million with an equity round joined by Boston Scientific (NYSE:BSX). Australia- and Bloomington, Minn.-based Saluda said Redmile Group and “one other financial institution” participated in the round. Yesterday the company took out a four-year term loan from Medtronic for an unspecified amount, marking […]
Saluda Medical wins another investment from Medtronic
Saluda Medical said today that it took out a four-year term loan from Medtronic (NYSE:MDT) for an unspecified amount, marking the medtech titan’s third investment in the spinal cord stimulation device maker. In May 2017, Australia- and Bloomington, Minn.-based Saluda raised nearly $40 million for the Evoke closed-loop neuromodulation device it’s developing to treat axial […]
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 35
- Next Page »
